A R T I C L E S
Borst et al.
column chromatography (toluene:pentane:THF ) 17:66:1), yielding
several fractions. The first fraction (Rf ) 0.57) contained benzophos-
phepine 1e (50.3 mg, 25%). Fraction 2 (Rf ) 0.36) contained mainly
(∼75%) meso-10e, part of which could be obtained pure after succesive
crystallizations from hexane/dichloromethane. Fraction 3 (Rf ) 0.13)
was rac-10e (54.1 mg, 14%). Small, yellowish needles could be
obtained from chloroform or diethyl ether.
COax), 205.0 (d, 2JCP ) 8.8 Hz, COeq), 204.5 (d, 2JCP ) 9.1 Hz, COeq),
1
1
138.0 (d, JCP ) 24.6 Hz, ipso-C), 136.7 (d, JCP ) 32.8 Hz, ipso-C),
136.4 (m, C7), 133.0 (d, 2JCP ) 7.0 Hz, C8), 128.1-129.8 (m, C9-12
1
2
1
+ ArC), 38.1 (dd, JCP ) 13.5 Hz, JCP ) 5.2 Hz, C5), 36.6 (dd, JCP
2
1
2
) 14.3 Hz, JCP ) 6.0 Hz, C2), 27.0 (dd, JCP ) 20.0 Hz, JCP ) 9.1
Hz, C6), 26.1 (dd, JCP ) 15.3 Hz, JCP ) 5.6 Hz, C3). 1H NMR
1
2
(CDCl3): δ 6.79-7.60 (m, 14H, H9-H12 + ArH), 4.12-4.21 (m,
2
3
1H, H2), 3.85 (ddm, JHP ) 19.9 Hz, JHH ) 6.4 Hz, H5), 3.29 (ddm,
2JHH ) 14.6 Hz, 3JHH ) 1.2 Hz, 1H, H3a), 2.89 (ddm, 2JHH ) 14.6 Hz,
3JHH ) 7.1 Hz, 1H, H3b), 2.72-2.84 (m, 2H, H6a-b). IR (KBr): ν )
2071.0 (m), 1991.2 (m), 1930.1 (s), 1914.1 (s) (CtO) cm-1. MS m/z
(%): 822 (18) [M+], 738 (30), [M+ - 3CO], 444 (50) [M+
Mo(CO)10], 346 (100) [M+ - Mo2(CO)10], 149 (100) [C9H10P+].
rac-10b: Mp: 116 °C (dec). 31P NMR (CDCl3): δ 19.7 (1JPMo
-
)
26.2 Hz).13C NMR (CDCl3): δ 209.8 (d, 2JCP ) 24.8 Hz, COax), 204.5
1
2
3
(m, COeq), 136.8 (d, JCP ) 25.0 Hz, ipso-ArC), 135.8 (t, JCP ) JCP
) 3.3 Hz, C7, C8), 129.6 (s, C10, C11), 128.5-129.2 (m, C9, C12,
o+m+p-ArC), 37.5 (m, C2, C5), 27.4 (m, C3, C6). 13C NMR
3
meso-10e: Mp: 174-175 °C. 31P NMR (CDCl3): δ -15.0 (d, JPP
) 17.4 Hz, 1JPW ) 246.9 Hz), -16.6 (d, 3JPP ) 17.4 Hz, 1JPW ) 235.0
Hz). 13C NMR (CDCl3): δ 198.6 (d, 2JCP ) 23.5 Hz, COax), 197.6 (d,
2
(CDCl3): δ 209.8 (d, JCP ) 24.8 Hz, COax), 204.5 (m, COeq), 136.8
(d, JCP ) 25.0 Hz, ipso-ArC), 135.8 (t, JCP ) JCP ) 3.3 Hz, C7,
C8), 129.6 (s, C10, C11), 128.5-129.2 (m, C9, C12, o+m+p-ArC),
2
1
2JCP ) 22.2 Hz, COax), 196.7 (d, JCP ) 6.7 Hz, JCW ) 118.1 Hz,
1
2
3
2
1
COeq), 196.0 (d, JCP ) 7.1 Hz, JCW ) 132.6 Hz, COeq), 135.8 (m,
2
3
C7), 134.3 (dd, JCP ) 6.6 Hz, JCP ) 1.8 Hz, C8), 129.0-129.2 (m,
C9-C11), 128.0 (t, 3JCP ) 4JCP ) 3.2 Hz, C12), 39.1 (dd, 1JCP ) 20.4
Hz, 2JCP ) 5.7 Hz, C5), 38.5 (dd, 1JCP ) 19.8 Hz, 2JCP ) 5.8 Hz, C2),
1
37.5 (m, C2, C5), 27.4 (m, C3, C6). H NMR (CDCl3): δ 7.45-7.57
(m, 4H, H9-H12), 7.20-7.27 (m, 6H, m+p ArH), 6.95-7.00 (m, 4H,
o-ArH), 4.14 (ddd, 2JHP ) 22.3 Hz, 3JHH ) 5.2 Hz, 3JHH ) 2.3 Hz, 2H,
1
2
1
30.0 (dd, JCP ) 26.9 Hz, JCP ) 6.0 Hz, C6), 29.1 (dd, JCP ) 21.6
2
3
3
H2, H5), 3.11 (ddd, JHH ) 14.5 Hz, JHP ) 3.3 Hz, JHH ) 2.3 Hz,
2H, H3a, H6a), 2.53 (ddd, 2JHP ) 21.8 Hz, 2JHH ) 14.5 Hz, 3JHH ) 5.2
Hz, 2H, H3b, H6b). IR (KBr): ν ) 2070.3 (s), 1988.6 (sh), 1939.9
(m), 1916.1 (s) (CtO) cm-1. HRMS Calcd for C32H20O10P2Mo2,
821.8640. Found 821.8803. MS m/z (%): 822 (50) [M+], 738 (72) [M+
- 3CO], 682 (60) [M+ - 5CO], 542 (15) [M+ - 10CO], 444 (50)
[M+ - Mo(CO)10], 346 (100) [M+ - Mo2(CO)10].
Hz, 2JCP ) 5.5 Hz, C3), 22.1 (d, 1JCP ) 28.7 Hz, CH3P4), 19.9 (d, 1JCP
1
) 18.4 Hz, CH3P1). H NMR (CDCl3): δ 7.37-7.43 (m, 3H, H9-
H11), 7.19-7.21 (m, 1H, H12), 3.67 (dddd, JHP ) 19.9 Hz, JHP
5.0 Hz, JHH ) 5.1, JHH ) 2.1 Hz, 1H, H2), 3.40 (ddm, JHP ) 19.9
Hz, JHH ) 4.1 Hz, H5), 2.77 (dddm, JHP ) 7.5 Hz, JHH ) 15.1 Hz,
3JHH ) 2.1 Hz, 1H, H3a), 2.61 (dm, 3JHH ) 4.1 Hz, 2H, H6a-b), 2.07
(d, 2JHP ) 6.1 Hz, 3H, CH3P1), 1.98 (ddm, 2JHH ) 15.1 Hz, 3JHH ) 5.1
2
3
)
3
3
2
3
3
2
11d: Isolated with phosphepine 1d. Data obtained from differential
2
Hz, 1H, H3b), 1.04 (d, JHP ) 5.9 Hz, 3H, CH3P4). IR (KBr): ν )
1
spectra. 31P NMR (CDCl3): δ 4.3 (d, JPH ) 348 Hz). 1H NMR
2068.0 (s), 1982.0 (s), 1952.3 (sh), 1939.6 (sh), 1921.3 (sh), 1910.6
(sh), 1899.9 (s) (CtO) cm-1. HRMS Calcd for C22H16W2P2O10,
869.9237. Found 869.92623. MS m/z (%): 870 (100) [M+], 786 (92)
[M+ - 3CO], 758 (52) [M+ - 4CO].
3
3
(CDCl3): δ 7.50 (ddm, JHP ) 28.9 Hz, JHH ) 12.8 Hz, 1H, Ar-
CHd), 7.27-7.57 (m, 9H, ArH), 6.29 (ddd, 2JHP ) 25.7 Hz, 3JHH(C)
)
3
1
12.8 Hz, JHH(P) ) 11.2 Hz, 1H, dCH-P), 6.17 (ddd, JHP ) 347.7
3
4
Hz, JHH ) 11.2 Hz, JHH ) 1.0 Hz, 1H, PH), 3.27 (s, 1H, CCH). IR
(KBr): ν ) 3301.06 (w), 2957.6 (w), 2942.6 (w), 2863.3 (w), 2063.4
(m, CtO), 1983.5 (sh, CtO), 1937.4 (s, CtO), 1260.5 (w), 1093.9
(br, m), 1022.3 (br, m), 799.6 (m), 762.3 (w), 627.0 (s), 650.9 (s, CCH)
rac-10e: Mp: 170 °C (dec). 31P NMR (CDCl3): δ -15.7 (1JPW
)
249.2 Hz). 13C NMR (CDCl3): δ 198.7 (m, COax), 196.0 (m, COeq),
136.0 (m, C7, C8), 129.6 (m, C10, C11), 129.1 (m, C9, C12), 38.4 (m,
1
C2, C5), 28.6 (m, C3, C6), 19.0 (m, CH3). H NMR (CDCl3): δ 7.40
cm-1
.
2
3
3
(s, 4H, H9-H12), 3.64 (ddd, JHP ) 22.7 Hz, JHH ) 5.3 Hz, JHH
)
2.1 Hz, 2H, H2, H5), 2.67 (ddm, 2JHH ) 14.9 Hz, 3JHH ) 2.1 Hz, 2H,
H3a, H6a), 2.54 (ddm, 2JHH ) 14.9 Hz, 3JHH ) 5.3 Hz, 2H, H3b, H6b).
2.07 (d, 2JHP ) 6.1 Hz, 6H, CH3P). IR (KBr): ν ) 2068.1 (m), 1985.4
(m), 1926.4 (s), 1909.8 (s), 1895.0 (s) (CtO) cm-1. HRMS Calcd for
C22H16W2P2O10: 869.9238. Found: 869.9254. MS m/z (%): 870 (<1)
[M+], 590 (<1) [M+ - 10CO], 472 (20) [M+ - 10CO - CH3 - C8H7],
430 (100) [W2P2+].
Evidence for Disproportionation of 3a. A mixture of 3a (10.5 mg,
0.024 mmol) and 3h (10.9 mg, 0.025 mmol) was dissolved in THF
(0.5 mL). The resulting solution was monitored by 31P NMR. Alongside
the signals attributed to 3a (-89.4 ppm, s) and 3h (-90.6, q, JPD
53.7 Hz) the signal of PhPHD-W(CO)5 grew in: -90.0 (t, JPD
1
)
)
1
53.7 Hz). After 2 h an equilibrium is reached, with the following
intensities: PH2:PHD:PD2 ) 1.0:0.4:0.7.
General Procedure for Phosphinidene Reactions. The benzophos-
phepine complex and substrate were dissolved in dry toluene (20 mL/
mmol) and placed in an oil bath at the reaction temperature until
completion. The solvent was evaporated, followed by sublimation of
naphthalene at 60 °C/1-2 mmHg. The residue was purified by column
chromatography (pentane, then pentane:Et2O ) 1:4) when necessary
and/or crystallization (pentane, -20 °C).
1,4-Diphenyl-2,5-[1,2]benzeno-1,4-diphosphinane Bis(pentacar-
bonylmolybdenum(0)) (10b). To a suspension of KOH (0.24 g) in
THF (16.0 mL) was added simultaneously a solution of 2 (0.85 mmol,
0.5 M in THF, 1.7 mL) and 3b (1.47 mmol, 0.49 M in THF, 3.0 mL).
The solution turned red immediately and was stirred overnight at room
temperature. After filtration over a short silica plug and evaporation
of the solvent, the crude product mixture was separated by column
chromatography (Et2O:pentane ) 1:4), yielding several fractions. The
first fraction (Rf ) 0.57) contained mostly benzophosphepine 1b, which
was purified by crystallization (43.1 mg, 0.091 mmol, 11%). The second
fraction (Rf ) 0.43, 106 mg) was a mixture of the benzophosphepine
(5%) and the two isomers of 10b (rac, 67%; meso, 29%). rac-10b could
be isolated in pure form after fractional crystallization from DCM/
pentane. meso-10b could be obtained almost pure (>95%), also by
crystallization from DCM/pentane.
15d:18 1.5 equiv of tolane and 11 h at 85 °C gave yellow crystals
(75%). 31P NMR (CDCl3): δ -109.2.13C NMR (CDCl3): δ 220.3 (d,
2
1
2JCP ) 5.8 Hz, COax), 216.3 (d, JCP ) 16.4 Hz, COeq), 138.7 (d, JCP
) 1.9 Hz, ipso-ArP), 130.9 (d, 2JCP ) 14.4 Hz, o-ArP), 130.6 (s, p-ArC),
130.4 (d, JCP ) 5.0 Hz, o-ArC), 130.3 (d, JCP ) 2.3 Hz, p-ArP),
129.3 (d, 1JCP ) 12.4 Hz, Cd), 129.3 (d, 4JCP ) 0.7 Hz, m-ArC), 128.6
(d, JCP ) 9.7 Hz, m-ArP), 127.4 (d, JCP ) 6.9 Hz, ipso-ArC). H
NMR (CDCl3): δ 7.88-7.92 (m, 4H, ArH), 7.45-7.58 (m, 8H, ArH),
7.27-7.35 (m, 3H, ArH).
3
4
3
2
1
meso-10b: Colorless blocks. Mp: 163 °C (dec). 31P NMR (CDCl3):
3
3
δ 27.2 (d, JPP ) 11.7 Hz), 25.1 (d, JPP ) 11.7 Hz). 13C NMR
16d:30 2.9 equiv of trans-stilbene and 11 h at 85 °C gave a light-
yellow solid (∼100%), which after crystallization became yellow
(CDCl3): δ 209.8 (d, 2JCP ) 25.2 Hz, COax), 208.9 (d, 2JCP ) 24.0 Hz,
9
16996 J. AM. CHEM. SOC. VOL. 127, NO. 48, 2005